Daniël J. Vis

8.8k citations
41 papers · 2.6k · 1 hit paper · h-index 18

Impact in

  • Analytical Chemistry top 2%
    • Spectroscopy and Chemometric Analyses
  • Molecular Biology top 5%
    • Metabolomics and Mass Spectrometry Studies
    • Bioinformatics and Genomic Networks
    • Ion channel regulation and function
    • Gene expression and cancer classification
    • Fungal and yeast genetics research

Papers in

  • Molecular Biology 18
    • Metabolomics and Mass Spectrometry Studies 7
    • Bioinformatics and Genomic Networks 6
    • Microbial Metabolic Engineering and Bioproduction 4
  • Surgery 9
    • Bladder and Urothelial Cancer Treatments 9
Co-authors
Age K. Smilde (11 shared papers)Johan A. Westerhuis (9 shared papers)Huub C. J. Hoefsloot (8 shared papers)John van Duynhoven (3 shared papers)Ewoud J. J. van Velzen (2 shared papers)Ferdi A. van Dorsten (2 shared papers)Suzanne Smit (1 shared paper)Lodewyk F.A. Wessels (22 shared papers)
Journals
Journal of Clinical Oncology (4 papers)Metabolomics (3 papers)PLoS ONE (2 papers)Annals of Oncology (2 papers)Nature Communications (2 papers)
Partner nations
NetherlandsUnited KingdomGermany

In The Last Decade

Daniël J. Vis

38 papers receiving 2.5k citations

Daniël J. Vis's Hit Papers

Assessment of PLSDA cross validation 2008 · 1.1k citations
1.1k0+6+12Years since publication2505007501000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

  • it has ≥500 total citations;
  • it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
  • it reaches the top citation threshold in at least one of its specific research topics.
  1. 2008 Metabolomics

Peers

Daniël J. Vis
Comparison fields: 5 of 155
  • Analytical Chemistry 264
  • Molecular Biology 1.5k
  • Biophysics 123
  • Cancer Research 173
  • Spectroscopy 164
Replace Eva Borràs with:
Eva Borràs Spain
Chen Meng China
Frode S. Berven Norway
Conrad Bessant United Kingdom
Leming Shi United States
Elwin Verheij Netherlands
Pär Jonsson Sweden
Nobuhiro Zaima Japan
Weiyang Chen China
Ferdi A. van Dorsten Netherlands
Daniël J. Vis relative to Eva Borràs Spain Eva Borràs's profile →
Citations per field
00.5×1.5×2×2.4×
Eva Borràs · 1×
Citations per year

Countries citing papers authored by Daniël J. Vis

Since Specialization
Citations

This map shows the geographic impact of Daniël J. Vis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniël J. Vis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniël J. Vis more than expected).

Fields of papers citing papers by Daniël J. Vis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniël J. Vis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniël J. Vis. The network helps show where Daniël J. Vis may publish in the future.

Co-authors

The 25 scholars most cited alongside Daniël J. Vis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Daniël J. Vis Line = papers co-authored together Daniël J. Vis links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Assessment of PLSDA cross validation
Metabolomics ·Johan A. Westerhuis, Huub C. J. Hoefsloot, Suzanne Smit, Daniël J. Vis, Age K. Smilde, Ewoud J. J. van Velzen, John van Duynhoven, Ferdi A. van Dorsten
Hit paper breakdown →		20081148
2
Subunit composition of VRAC channels determines substrate specificity and cellular resistance to Pt‐based anti‐cancer drugs
The EMBO Journal ·Rosa Planells‐Cases, Darius Lutter, Charlotte Guyader, Nora M. Gerhards, Florian Ullrich, Deborah A Elger, Aslι Küçükosmanoğlu, Guotai Xu, Felizia K. Voss, S. Momsen Reincke, Tobias Stauber, Vincent A. Blomen, Daniël J. Vis, Lodewyk F.A. Wessels, Thijn R. Brummelkamp, Piet Borst, Sven Rottenberg, Thomas J. Jentsch
2015211
3
T-profiler: scoring the activity of predefined groups of genes using gene expression data
Nucleic Acids Research ·André Boorsma, Barrett C. Foat, Daniël J. Vis, Frans M. Klis, Harmen J. Bussemaker
2005163
4
Statistical validation of megavariate effects in ASCA
BMC Bioinformatics ·Daniël J. Vis, Johan A. Westerhuis, Age K. Smilde, J. van der Greef
2007133
5
Genome-wide analysis of yeast stress survival and tolerance acquisition to analyze the central trade-off between growth rate and cellular robustness
Molecular Biology of the Cell ·Anna Zakrzewska, Gerco van Eikenhorst, Johanna E. C. Burggraaff, Daniël J. Vis, Huub C. J. Hoefsloot, Daniela Delneri, Stephen G. Oliver, Stanley Brul, Gertien J. Smits
2011128
6
Intra‐ and inter‐tumor heterogeneity in a vemurafenib‐resistant melanoma patient and derived xenografts
EMBO Molecular Medicine ·Kristel Kemper, Oscar Krijgsman, Paulien Cornelissen‐Steijger, Aida Shahrabi, Fleur Weeber, Ji‐Ying Song, Thomas Kuilman, Daniël J. Vis, Lodewyk F.A. Wessels, Emile E. Voest, Ton N. Schumacher, Christian U. Blank, David J. Adams, John B.A.G. Haanen, Daniel S. Peeper
2015103
7
Dynamic metabolomic data analysis: a tutorial review
Metabolomics ·Age K. Smilde, Johan A. Westerhuis, Huub C. J. Hoefsloot, Sabina Bijlsma, Carina M. Rubingh, Daniël J. Vis, Renger H. Jellema, Hanno Pijl, Ferdinand Roelfsema, J. van der Greef
200986
8
MAP3K1 and MAP2K4 mutations are associated with sensitivity to MEK inhibitors in multiple cancer models
Cell Research ·Xue Zheng, Daniël J. Vis, Alejandra Bruna, Tonći Šuštić, Sake van Wageningen, Ankita Sati Batra, Oscar M. Rueda, Evert Bosdriesz, Carlos Caldas, Lodewyk F.A. Wessels, René Bernards
201883
9
Phenotyping Tea Consumers by Nutrikinetic Analysis of Polyphenolic End-Metabolites
Journal of Proteome Research ·Ewoud J. J. van Velzen, Johan A. Westerhuis, John van Duynhoven, Ferdi A. van Dorsten, Christian H. Grün, Doris M. Jacobs, Guus Duchateau, Daniël J. Vis, Age K. Smilde
200975
10
TANDEM: a two-stage approach to maximize interpretability of drug response models based on multiple molecular data types
Bioinformatics ·Nanne Aben, Daniël J. Vis, Magali Michaut, Lodewyk F.A. Wessels
201655
11
Identification of a Druggable Pathway Controlling Glioblastoma Invasiveness
Cell Reports ·Nora Pencheva, Mark C. de Gooijer, Daniël J. Vis, Lodewyk F.A. Wessels, Tom Würdinger, Olaf van Tellingen, René Bernards
201750
12
Multilevel models Improve precision and Speed of IC 50 Estimates
Pharmacogenomics ·Daniël J. Vis, Lorenzo Bombardelli, Howard Lightfoot, Francesco Iorio, Mathew J. Garnett, Lodewyk F.A. Wessels
201639
13
Evaluation of the HER/PI3K/AKT Family Signaling Network as a Predictive Biomarker of Pathologic Complete Response for Patients With Breast Cancer Treated With Neratinib in the I-SPY 2 TRIAL
JCO Precision Oncology ·Julia Wulfkuhle, Christina Yau, Denise M. Wolf, Daniël J. Vis, Rosa I. Gallagher, Lamorna Brown Swigart, Gillian L. Hirst, Emile E. Voest, Angela DeMichele, Nola M. Hylton, Fraser Symmans, Douglas Yee, Laura J. Esserman, Donald A. Berry, Minetta C. Liu, John W. Park, Lodewyk F.A. Wessels, Laura van’t Veer, Emanuel F. Petricoin
201834
14
The Tumor Immune Landscape and Architecture of Tertiary Lymphoid Structures in Urothelial Cancer
Frontiers in Immunology ·Nick van Dijk, Alberto Gil-Jimenez, Karīna Siliņa, Maurits L. van Montfoort, Sarah Einerhand, Lars Jonkman, Charlotte S. Voskuilen, Dennis Peters, Joyce Sanders, Yoni Lubeck, Annegien Broeks, Erik Hooijberg, Daniël J. Vis, Maries van den Broek, Lodewyk F.A. Wessels, Bas W.G. van Rhijn, Michiel S. van der Heijden
202130
15
Assessment of Predictive Genomic Biomarkers for Response to Cisplatin-based Neoadjuvant Chemotherapy in Bladder Cancer
European Urology ·Alberto Gil-Jimenez, Jeroen van Dorp, Alberto Contreras‐Sanz, Kristan van der Vos, Daniël J. Vis, Linde M. Braaf, Annegien Broeks, Ron Kerkhoven, Kim E.M. van Kessel, María J. Ribal, Antonio Alcaraz, Lodewyk F.A. Wessels, Roland Seiler, Jonathan L. Wright, Lourdes Mengual, Joost L. Boormans, Bas W.G. van Rhijn, Peter C. Black, Michiel S. van der Heijden
202229
16
TLE3 loss confers AR inhibitor resistance by facilitating GR-mediated human prostate cancer cell growth
eLife ·Sander Palit, Daniël J. Vis, Suzan Stelloo, Cor Lieftink, Stefan Preković, Elise M. Bekers, Ingrid Hofland, Tonći Šuštić, Liesanne Wolters, Roderick L. Beijersbergen, Andries M. Bergman, Balázs Győrffy, Lodewyk F.A. Wessels, Wilbert Zwart, Michiel S. van der Heijden
201927
17
Predicting patient response with models trained on cell lines and patient-derived xenografts by nonlinear transfer learning
Proceedings of the National Academy of Sciences ·Soufiane Mourragui, Marco Loog, Daniël J. Vis, Kat Moore, Anna G. Manjón, Mark A. van de Wiel, Marcel Reinders, Lodewyk F.A. Wessels
202126
18
Analyzing metabolomics-based challenge tests
Metabolomics ·Daniël J. Vis, Johan A. Westerhuis, Doris M. Jacobs, John van Duynhoven, Suzan Wopereis, Ben van Ommen, Margriet M. W. B. Hendriks, Age K. Smilde
201420
19
Towards a global cancer knowledge network: dissecting the current international cancer genomic sequencing landscape
Annals of Oncology ·Daniël J. Vis, Jeremy Lewin, Rachel G. Liao, M. Mao, Fabrice André, Robyn L. Ward, Felipe A. Calvo, Bin Tean Teh, Anamaria A. Camargo, Bartha Maria Knoppers, Charles L. Sawyers, Lodewyk F.A. Wessels, Mark Lawler, Lillian L. Siu, Emile E. Voest
201716
20
A kinome-centered CRISPR-Cas9 screen identifies activated BRAF to modulate enzalutamide resistance with potential therapeutic implications in BRAF-mutated prostate cancer
Scientific Reports ·Sander Palit, Jeroen van Dorp, Daniël J. Vis, Cor Lieftink, Simon Linder, Roderick L. Beijersbergen, Andries M. Bergman, Wilbert Zwart, Michiel S. van der Heijden
202113

About Daniël J. Vis

Daniël J. Vis is a scholar working on Molecular Biology, Surgery, Pulmonary and Respiratory Medicine, Oncology and Computational Theory and Mathematics, having authored 41 papers that have together received 2.6k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (9 papers), Metabolomics and Mass Spectrometry Studies (7 papers), Bioinformatics and Genomic Networks (6 papers), Computational Drug Discovery Methods (5 papers), Prostate Cancer Treatment and Research (5 papers), Cancer Immunotherapy and Biomarkers (4 papers), Microbial Metabolic Engineering and Bioproduction (4 papers) and Ferroptosis and cancer prognosis (3 papers). The work is most often cited by research in Analytical Chemistry (264 citations), Molecular Biology (1.5k citations), Biophysics (123 citations), Cancer Research (173 citations) and Spectroscopy (164 citations). Daniël J. Vis has collaborated with scholars based in Netherlands, United Kingdom and Germany. Frequent co-authors include Age K. Smilde, Johan A. Westerhuis, Huub C. J. Hoefsloot, John van Duynhoven, Ewoud J. J. van Velzen, Ferdi A. van Dorsten, Suzanne Smit, Lodewyk F.A. Wessels, J. van der Greef and André Boorsma. Their work appears in journals such as Journal of Clinical Oncology, Metabolomics, PLoS ONE, Annals of Oncology and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eva BorràsBreakdown of academic impact, for papers by Chen MengBreakdown of academic impact, for papers by Frode S. BervenBreakdown of academic impact, for papers by Conrad BessantBreakdown of academic impact, for papers by Leming ShiBreakdown of academic impact, for papers by Elwin VerheijBreakdown of academic impact, for papers by Pär JonssonBreakdown of academic impact, for papers by Nobuhiro ZaimaBreakdown of academic impact, for papers by Weiyang ChenBreakdown of academic impact, for papers by Ferdi A. van Dorsten